During the past decade, Clínica San Pablo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clínica San Pablo" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Asthma" (1 trials), "Atrial Fibrillation" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Clínica San Pablo" in a lesser frequency.

Most popular intervention types in "Clínica San Pablo" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lebrikizumab" (2 trials), "Clopidogrel" (1 trials), "Pamrevlumab" (1 trials) and "Pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clínica San Pablo" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Clínica San Pablo". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clínica San Pablo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clínica San Pablo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".